Font Size: a A A
Keyword [CRPC]
Result: 41 - 60 | Page: 3 of 5
41. Establishment Of Human Prostate Cancer Abiraterone-resistant Cell Line And The Study Of Drug-resisitance Mechanism
42. Erastin Downregulates Androgen Receptor And Its Splice Variants In Prostate Cancer
43. Clinical Factors About Patients With Prostate Cancer Giving ADT Progressing To CRPC
44. Predictive Significance Of Gleason Score On Prostate Cancer Outcome
45. Prognosis Analysis Of Prostate Cancer And Mechanism Research Of TSPAN1 In Disease Progression
46. The Study Of Anti-tumor Effects And Underlying Mechanism Of Proscillaridin A On The Prostate Cancer
47. Correlation Between Testosterone Concentration Control And Disease Progression In Patients With Metastatic Hormone-sensitive Prostate Cancer(mHSPC)
48. Effect Of Upregulation Of Numb Gene In CRPC Cells On Cell Cycle Through Hedgehog Signaling Pathway
49. The Therapeutic Effect Of TURP Plus Novel Endocrine Therapy On Patients In Their Terminal Stage Of CRPC With BOO
50. Correlation Between Peri-Prostatic Fat And High-Risk Prostate Cancer
51. Abrogating the Protumorigenic Impact of Tumor-Infiltrating Myeloid Cells During Prostate Cancer Therapy
52. Simultaneous targeting of endoplasmic reticulum stress and AKT pathways as a novel chemosensitization approach against castration resistant prostate cancer
53. TMPRSS2-ERG regulation of androgen biosynthetic enzyme expression, DHT synthesis, and androgen receptor activation in prostate cancer
54. Castration Agitating Neurotensin Paracrine Network In Microenviroment Promotes Neuroendocrine Differentiation In Prostate Cancer
55. LncRNA-CYTOR/SRSF4/7 RNA-protein Complex Promotes Crpc Progression Through Regulating Alternative Splicing Of AR-V7
56. Preliminary Study On LncRNA CYTOR Promotes The Resistance To Abirateronein CRPC
57. MDSCs Drive Metastasis And Castration Resistance In Prostate Cancer By Mobilizing Autocrine Wnt/PCP
58. The Role Of CCAT1 In Prostate Cancer Progression And Its Regulation Mechanisms
59. The Mechanism Of IL-6/STAT3 Regulating FGG To Promote Progression Of Prostate Cancer
60. The Mechanisms Underlying KAT2A-mediated AR Translocation Into Nucleus In Castration-resistant Prostate Cancer Cell With Abiraterone-Resistance
  <<First  <Prev  Next>  Last>>  Jump to